At 13.3x earnings and 12.7x forward earnings, DHT is priced like a no-growth cyclical despite generating a 14.80% ROIC and carrying an Altman Z-Score of 4.3, which signals strong balance sheet safety. The combination of a Piotroski F-Score of 7 and a 2.8 current ratio suggests operational discipline and liquidity strength that the market is not rewarding. However, the 1.4 PEG Forward implies growth is not explosive, so this is not a hyper-growth story—it’s a balance-sheet-secure, cash-generating midstream operator priced for skepticism rather than distress. The market appears cautious, but not pricing in financial fragility.